Aoife Mcvey
Geelong, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 30, 2024
Re: Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-inferiority, Confirmatory Study.
Journal: European urology
Published: July 11, 2024
'Case of the Month' from Peter MacCallum Cancer Centre, Melbourne, Australia: insidious presentation of iatrogenic renal pelvis injury following ureteric cannulation with 5-F catheter diagnosed on unconventional mercaptoacetyltriglycine and single-photon emission computed tomography imaging.
Journal: BJU international
Published: December 27, 2023
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.
Journal: European urology oncology
Published: June 30, 2023
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.
Journal: European urology
Published: June 06, 2023
Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE).
Journal: European urology
Published: April 08, 2023
Recent developments in the diagnosis and management of N1 penile cancer.
Journal: Current opinion in urology
Published: November 29, 2022
Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?
Journal: Nature reviews. Urology
Published: October 10, 2022
Modern paradigms for prostate cancer detection and management.
Journal: The Medical journal of Australia
Published: May 19, 2022
Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer.
Journal: BJU international
Published: May 16, 2022
Re: Armando Stabile, Antony Pellegrino, Elio Mazzone, et al. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. Eur Urol Oncol 2022;5:1-17.
Journal: European urology oncology
Published: March 04, 2022
Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer.
Journal: European urology
Published: February 22, 2022
Last Updated: 09/26/2026